Severe symptomatic hypocalcaemia following a single dose of denosumab

Saved in:
Bibliographic Details
Published inMedical journal of Australia Vol. 199; no. 4; p. 242
Main Authors McLachlan, Jennifer M, Marx, Gavin M, Bridgman, Margaret
Format Journal Article
LanguageEnglish
Published Australia 01.08.2013
Subjects
Aged, 80 and over
Antibodies, Monoclonal, Humanized - administration & dosage
Antibodies, Monoclonal, Humanized - adverse effects
Bone Neoplasms - drug therapy
Bone Neoplasms - secondary
Breast Neoplasms - drug therapy
Breast Neoplasms - pathology
Denosumab
Dose-Response Relationship, Drug
Female
Humans
Hypocalcemia - chemically induced
Hypocalcemia - therapy
Risk Factors
Treatment Outcome
Online AccessGet more information

Cover

More Information
ISSN:1326-5377
DOI:10.5694/mja13.10038